Edgewood Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-7,629,399
Closed -$479M 92
2026
Q1
$479M Sell
7,629,399
-173,866
-2% -$13.9M 3.09% 17
2025
Q4
$744M Sell
7,803,265
-1,497,825
-16% -$147M 3.54% 17
2025
Q3
$908M Buy
9,301,090
+2,349,640
+34% +$243M 3.22% 17
2025
Q2
$747M Buy
+6,951,450
New +$703M 2.37% 21

Other funds holding BSX

Edgewood Management's BSX Position: Q2 2026 in Review

Edgewood Management sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 7,629,399 shares — an estimated $479M sold.

Edgewood Management first reported a position in BSX in Q2 2025 and held it in 4 quarters. The position peaked at $908M in Q3 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Edgewood Management reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Edgewood Management sold 7,629,399 Boston Scientific shares in Q2 2026, an estimated $479M.
  • Edgewood Management first reported a position in Boston Scientific in Q2 2025 and held it in 4 quarters.
  • Edgewood Management's Boston Scientific position peaked at $908M in Q3 2025.
  • 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Edgewood Management's 13F filing for Q2 2026, filed 13 Aug 2026.